Prostate Cancer Update: A CME Audio Series and Activity

STATEMENT OF NEED/TARGET AUDIENCE

Prostate cancer is one of the most rapidly evolving fields in urology. Published results from clinical trials lead to the emergence of new surgical and radiation therapy techniques and therapeutic agents, along with changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing urologist and radiation oncologist must be well-informed of these advances. To bridge the gap between research and patient care, Prostate Cancer Update utilizes one-on-one discussions with leading urologic oncology investigators. By providing access to the latest research developments and expert perspectives, this CME program assists urologists and radiation oncologists in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

• Critically evaluate the clinical implications of emerging clinical trial data in prostate cancer treatment.
• Inform patients about the specific risks and benefits of local and systemic therapies.
• Provide individualized counseling to patients regarding the choice and timing of endocrine therapy.
• Offer patients information regarding their prognosis with and without various therapeutic options.
  

SPECIFIC LEARNING OBJECTIVES FOR ISSUE 5

Upon completion of this activity, participants should be able to:

• Discuss current trends in the use of radiation therapy for the management of prostate cancer.
  
• Review the role of brachytherapy and external beam radiation therapy combined with hormone therapy in the management of prostate cancer.
  
• Counsel patients who experience PSA recurrence after radical prostatectomy about potential treatment options, including radiation therapy and hormonal therapy.
  
• Counsel patients about the important outcome measures for radical prostatectomy, including the potential side effects.
  
• Discuss the role of intermittent androgen suppression with patients who are being counseled about hormonal therapy options.
  

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only credits that he/she actually spent on the activity.

Home

Editor’s Note

Michael J Zelefsky, MD
    - Select publications

Joseph A Smith Jr, MD
    - Select publications

Michael K Brawer, MD
    - Select publications

Editor’s Office